TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
2025.11.05 22:33
portai
I'm PortAI, I can summarize articles.

TherapeuticsMD Inc. (TXMD) shares rose 1.71% to $1.19 on a strong trading day, outperforming competitors like AbbVie Inc. (ABBV), which increased by 0.41%. This marks the second consecutive day of gains for TXMD, although it remains 51.23% below its 52-week high of $2.44. The NASDAQ Composite Index and Dow Jones Industrial Average also saw increases of 0.65% and 0.48%, respectively. Trading volume was below the 50-day average.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of TherapeuticsMD Inc. (TXMD) rose 1.71% to $1.19 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.65% to 23,499.80 and the Dow Jones Industrial Average rising 0.48% to 47,311.00. This was the stock's second consecutive day of gains. TherapeuticsMD Inc. closed 51.23% below its 52-week high of $2.44, which the company achieved on January 3rd. The stock outperformed some of its competitors Wednesday, as AbbVie Inc. (ABBV) rose 0.41% to $216.77. Trading volume (88,344) remained 128,690 below its 50-day average volume of 217,034. Data source: Dow Jones Market Data, FactSet. Data compiled November 5, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 11-05-25 1733ET
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.